Buy Melinta Therapeutics Stock | CEMP Stock Price & Latest News | Public
CEMP

Melinta Therapeutics

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    About CEMP

    Melinta Therapeutics, Inc. operates as a commercial-stage pharmaceutical company which engages in developing and commercializing anti-infective s for the hospital and selected non-hospital or communities. It markets antibiotics including Baxdela, Vabomere, Orbactiv, and...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    Stats

    Market Cap$1,51M
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$8.60
    1 Year Low$0.06
    Open
    High
    Low

    Buy any stock with any amount of money.

    Download the App
    Download the app